Susp. Erythin 125 mg / 5 ml information and price in Bangladesh

Information: Susp. Erythin 125 mg / 5 ml

Therapeutic action – Macrolide antibacterial Indications Erythromycin is an alternative to first-line antibacterials when they are not available or contra-indicated: – Borreliosis (louse-borne and tick-borne relapsing fevers), non-venereal treponematoses, leptospirosis, conjunctivitis due to Chlamydia trachomatis – Acute otitis media, tonsillitis and sinusitis; diphtheria, pertussis, pneumonia due to Mycoplasma pneumoniae and Chlamydophila pneumoniae – Erysipela, impetigo, furuncle, leg ulcer – Cervicitis and urethritis due to Chlamydia trachomatis (in combination with a treatment for gonorrhoea), donovanosis, chancroid, lymphogranuloma venereum, syphilis – Completion treatment following parenteral therapy with erythromycin Presentation – 250 mg and 500 mg tablets – 125 mg/5 ml powder for oral suspension, to be reconstituted with filtered water Dosage – Louse-borne relapsing fever Child under 5 years: 250 mg as a single dose Child over 5 years and adult: 500 mg as a single dose age Weight 125 mg/5 ml susp. 250 mg tablet 500 mg tablet < 2 months < 5 kg ½ tsp x 2 ¼ tab x 2 − 2 to < 12 months 5 to < 10 kg 1 tsp x 2 ½ tab x 2 ¼ tab x 2 1 to < 3 years 10 to < 15 kg 2 tsp x 2 1 tab x 2 ½ tab x 2 3 to < 8 years 15 to < 25 kg 2 tsp x 3 1 tab x 3 ½ tab x 3 8 to < 11 years 25 to < 35 kg − 2 tab x 2 1 tab x 2 11 to < 13 years 35 to < 45 kg − 2 tab x 3 1 tab x 3 – Other indications Child: 30 to 50 mg/kg/day in 2 or 3 divided doses Adult: 2 to 3 g/day in 2 or 3 divided doses Duration – Tick-borne relapsing fever, leptospirosis, pertussis, cervicitis and urethritis, chancroid, impetigo, furuncle, leg ulcer: 7 days; sinusitis, erysipela: 7 to 10 days; tonsillitis, otitis: 10 days; atypical pneumonia:10 to 14 days; diphtheria, treponematoses, syphilis, lymphogranuloma venereum, donovanosis, conjunctivitis due to C. trachomatis: 14 days. Contra-indications, adverse effects, precautions – Do not administer to patients with allergy to erythromycin or another macrolide. – Administer with caution to patients with renal impairment (max. 1.5 g/day for adult with severe renal impairment) or hepatic impairment. – May cause: gastrointestinal disturbances, reversible hearing disorders, heart rhythm disorders (QT prolongation); allergic reactions sometimes severe. In the event of allergic reaction, stop treatment immediately. – Avoid combination with drugs that prolong the QT interval (amiodarone, chloroquine, co-artemether, fluconazole, haloperidol, mefloquine, moxifloxacin, ondansetron, pentamidine, quinine, etc.). – Administer with caution and monitor use in patients taking carbamazepine or digoxin (increased their plasma levels). – Avoid use in neonates less than 2 weeks (risk of pyloric stenosis). – Pregnancy and breast-feeding: no contra-indication Remarks – Take tablets preferably one hour before or 2 hours after a meal. – Storage: below 25°C – – http://www.aci-bd.com/aci-pharmaceuticals/products.html https://medlineplus.gov/druginfo/meds/a682381.html https://en.wikipedia.org/wiki/Erythromycin

Caution: Susp. Erythin 125 mg / 5 ml

Before taking Susp. Erythin 125 mg / 5 ml, inform your doctor if you or your child have liver or kidney problems or any allergies. It should be used with caution in patients with liver problems due to alcohol to prevent the risk of liver damage.

Susp. Erythin 125 mg / 5 ml should be used with caution in pregnant women only if clearly advised by the doctor and can be used in breastfeeding women.

Susp. Erythin 125 mg / 5 ml is not recommended for use in children less than 10 years of age and should be used with caution in elderly patients.

Consult your doctor if you experience any side effects or unusual effects during treatment with Susp. Erythin 125 mg / 5 ml.

Safety: Susp. Erythin 125 mg / 5 ml

It is unsafe to consume alcohol with Susp. Erythin 125 mg / 5 ml